This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived at a point where they could read, write, and edit any sequence of DNA. But composing whole genes or even whole genomes from scratch — that was something only evolution could do. A few years later, not long after helping to launch the Arc Institute, a nonprofit research center in the Bay Area, molecular engineer Patrick Hsu wondered if it was possible to imitate the forces of evolution
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few months ago, the last trial expected to potentially deliver a vaccine within this decade was shut down. But HIV scientists are nothing if not resilient, and used to trying one new approach after another.
Just because the Food and Drug Administration has given the Apple Watch and other wearable devices the OK to market the health benefits of their tracking and algorithms doesn’t mean that the data they generate are useful for either patients or their doctors, experts said Thursday at the STAT Breakthrough Summit West in San Francisco. “Yesterday, I saw a patient with type 2 diabetes who has a continuous glucose monitor, and so she’s been tracking her blood sugar every five mi
Community pharmacy negotiators in Scotland will not begin conversations about how new hub and spoke legislation will affect NHS dispensing until the sector has its funding in place for 2024/25, Community Pharmacy Scotland (CPS) has confirmed to The Pharmacist. Meanwhile, negotiators in Northern Ireland have expressed disappointment that the government has proceeded with the spoke-hub-patient […] The post Hub and spoke discussions in Scotland won’t start until funding agreed, says CPS appea
Extreme weather fueled by accelerating climate change puts patients, providers, and health care facilities at severe risk, jeopardizing lives. Unpredictable shifts in weather patterns are creating new regional extremes , and communities have to adjust to survive. During climate crises, health care providers and facilities must be ready to quickly adapt to shifting needs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
When Black people receive maternal care, they are often not treated the same as white people. In 2016, when Simmone Taitt had her first pregnancy loss, she was very well insured, had a high-paying job as a tech executive, and had access to one of the top OB-GYNs in New York City. Yet, when she found out that her baby had no heartbeat, she left that appointment with no medical follow-up, and no emotional or mental health support.
SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health. “They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said.
Explore sustainable catalysis and its potential to transform chemical reactions in drug discovery. Learn how green chemistry plays a pivotal role in shaping the future of catalysis.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies. But to John-Arne Røttingen, the new head of the Wellcome Trust , one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.
There are currently no plans to replace the referral requirement of Pharmacy First with a walk-in approach, NHS England (NHSE) has suggested. At the Clinical Pharmacy Congress last week, NHSE’s clinical strategy for community pharmacy lead Pallavi Dawda confirmed that it was not considering removing the need for a GP referral for minor illnesses and […] The post Pharmacy First: No plans to replace referral requirement with walk-in approach appeared first on The Pharmacist.
As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage results of its heart drug, CEO Robert Blum maintains that the biotech can launch the treatment — what would be its first approved medication — on its own. Cytokinetics reported top-line results of its drug, aficamten, in obstructive hypertrophic cardiomyopathy, or oHCM, last December, sending its shares up on speculation the company would get acquired.
Brainomix gets FDA approval for e-Lung, an AI tool that assists in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from medical images.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascots, take in a moving picture, and hold another listening party, where the rotation will likely include this , this , this , this and this.
Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have had disease progression on or after platinum-based chemotherapy. The post FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer appeared first on Pharmafile.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Asking again! Could you tell us what you think of The Readout? Fill out this survey !
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of type 2 diabetes and obesity. With the obesity and type 2 diabetes markets growing at unprecedented rates, the GLP-1 receptor agonists market is also growing. GLP-1 receptor agonist sales for the type 2 diabetes and obesity markets are forecast to reach over $125 billion in the seven major markets (7MM*) by 2033, according to GlobalData.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Amgen gets FDA approval for Imdelltra as a treatment for small cell lung cancer, becoming the first DLL3-targeted drug and the company's second BiTE therapy.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content